IBB vs MSFT: Which Stock is Better?
Side-by-side comparison of Ishares Biotechnology Etf and Microsoft Corp in 2026
IBB
Ishares Biotechnology Etf
$176.22
MSFT
Microsoft Corp
$418.00
Key Metrics Comparison
| Metric | IBB | MSFT | Winner |
|---|---|---|---|
| Market Cap | N/A | N/A | Tie |
| P/E Ratio | N/A | 24.57 | MSFT |
| EPS (TTM) | $N/A | $16.00 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze IBB
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBB or MSFT a better investment?
Comparing IBB and MSFT: Ishares Biotechnology Etf has a market cap of N/A while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBB and MSFT?
IBB (Ishares Biotechnology Etf) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBB or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBB or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for IBB.
Which company is more profitable: IBB or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for IBB.
Which is the larger company: IBB or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of N/A compared to N/A for IBB.
Should I buy IBB or MSFT in 2026?
Both IBB and MSFT have investment merit. IBB trades at $176.22 while MSFT trades at $418.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBB and MSFT stock?
Key differences: Market Cap (N/A vs N/A), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).